Document: NUREG-0800
Document ID: 04c894f5-e3ab-479e-8bca-0722777c79a7
Document Type: srp
Title: Revision 4 – January 2016
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML1502/ML15027A401.pdf
Revision Date: 2023-06
Chapter: 11
Section ID: 11
CFR Part: 
CFR Title: 

Content:
ct human consumption. C. In complying with the above SRP dose acceptance criteria, this guidance does not relieve any applicant or license holder from complying with the dose limits of 10 CFR 20.1301, “Standards for Protection against Radiation,” 10 CFR 20.1301(e); and 10 CFR 20.1302, “Compliance with Dose Limits for Individual Members of the Public”; Column 2 effluent concentration limits and Note 4 of Appendix B to 10 CFR Part 20; and design objectives and as low as is reasonably achievable (ALARA) provisions of Appendix I, “Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion ‘As Low As Is Reasonably Achievable’ for Radioactive Material in Light-Water-Cooled Nuclear Power Reactor Effluents,” to 10 CFR Part 50. For the purpose of this BTP (and SRP Section 2.4.13), a receptor is defined as a member of the public assumed to consume and use water at a point of entry located in an unrestricted area. “Member of the public” means any individual who is not receiving an occupational dose. “Unrestricted area” means an area, access to which is neither limited nor controlled by the licensee (10 CFR 20.1003). The point of entry in an unrestricted area is assumed be a domestic well, or part or all of a fresh surface water body (e.g., stream, river, lake). In the context of this BTP, the point of entry is not the same as the point of discharge, in light of the definition given in RG 1.21 (“Measuring, Evaluating, and Reporting Radioactive Material in Liquid and Gaseous Effluents and Solid Waste,” Revision 2). Under this BTP (and SRP Section 2.4.13), radiological impacts associated with postulated accidental releases of radioactive materials are not used in demonstrating literal compliance with the requirements of 10 CFR 20.1301, 10 CFR 20.1302, and 10 CFR 20.1301(e) and design objectives and ALARA provisions of Appendix I to 10 CFR Part 50. Rather, the SRP dose acceptance criteria are defined as a measure